Fineline Cube

Follow:
14486 Articles
Aosaikang's AskGene Pharma Licenses ASKG712 to Visara for Macular Disease Treatment
CompanyDeals

Aosaikang’s AskGene Pharma Licenses ASKG712 to Visara for Macular Disease Treatment

Kelun-Biotech's Trastuzumab Botidotin Approved by NMPA for HER2-Positive Breast Cancer
CompanyDrug

Kelun-Biotech’s Trastuzumab Botidotin Approved by NMPA for HER2-Positive Breast Cancer

Huadong Medicine Secures NMPA Approval for Relmapirazin Injection, Complementing MediBeacon TGFR Device
CompanyDrug

Huadong Medicine Secures NMPA Approval for Relmapirazin Injection, Complementing MediBeacon TGFR Device

Kexing Biopharm & Easton Biopharma Sign Exclusive Overseas Licensing Deal for Apalutamide
CompanyDeals

Kexing Biopharm & Easton Biopharma Sign Exclusive Overseas Licensing Deal for Apalutamide

Sinclair’s MaiLi Precise Receives NMPA Acceptance Notice for Class III Device
CompanyMedical Device

Sinclair’s MaiLi Precise Receives NMPA Acceptance Notice for Class III Device

I‑Mab Announces Global Transformation, NovaBridge Rebranding, and $37 M Acquisition of VIS‑101
CompanyDeals

I‑Mab Announces Global Transformation, NovaBridge Rebranding, and $37 M Acquisition of VIS‑101

CStone’s Sugemalimab Receives Positive EMA Opinion for Stage III NSCLC
CompanyDrug

CStone’s Sugemalimab Receives Positive EMA Opinion for Stage III NSCLC

Viatris Acquires Aculys Pharma to Secure Japanese Rights for Pitolisant and Spydia
CompanyDeals

Viatris Acquires Aculys Pharma to Secure Japanese Rights for Pitolisant and Spydia

Gan & Lee Pharma, Fiocruz Sign MoU to Advance GZR4 and GZR102 Insulin Candidates
CompanyDeals

Gan & Lee Pharma, Fiocruz Sign MoU to Advance GZR4 and GZR102 Insulin Candidates

Hansoh Pharma Grants Roche Exclusive Global Rights to CDH17‑Targeting ADC HS‑20110
CompanyDeals

Hansoh Pharma Grants Roche Exclusive Global Rights to CDH17‑Targeting ADC HS‑20110

Shanghai Junshi Biosciences Secures FDA Approval for JS207 Phase II/III Trial
CompanyDrug

Shanghai Junshi Biosciences Secures FDA Approval for JS207 Phase II/III Trial

AstraZeneca China Integrates Symbicort and Breztri Sales Teams in New Organizational Shake‑Up
Company

AstraZeneca China Integrates Symbicort and Breztri Sales Teams in New Organizational Shake‑Up